Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Jensen

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Molecular Cancer Therapeutics|September 5, 2013
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activityShane A Olwill, Christian Joffroy, Hendrik Gille, et al.
Journal of Medicinal Chemistry|December 13, 2024
<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal InjuryH Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
Scientific Reports|May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
The Journal of Allergy and Clinical Immunology|January 2, 2023
Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthmaGabriele Matschiner, Mary F Fitzgerald, Ulrich Moebius, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 31, 2019
QuantumATK: an integrated platform of electronic and atomic-scale modelling toolsSøren Smidstrup, Troels Markussen, Pieter Vancraeyveld, et al.
Metabolic Engineering|February 4, 2023
Laboratory evolution reveals general and specific tolerance mechanisms for commodity chemicalsRebecca M Lennen, Hyun Gyu Lim, Kristian Jensen, et al.
Journal of Medicinal Chemistry|April 28, 2022
Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational PlatformHaifeng Tang, Kristian Jensen, Evelyne Houang, et al.
International Journal of Biological Sciences|February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genesLiwen Zhang, Timothy McCabe, Jon H Condra, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Molecular Cancer Therapeutics|September 5, 2013
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activityShane A Olwill, Christian Joffroy, Hendrik Gille, et al.
Journal of Medicinal Chemistry|December 13, 2024
<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal InjuryH Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
Scientific Reports|May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
The Journal of Allergy and Clinical Immunology|January 2, 2023
Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthmaGabriele Matschiner, Mary F Fitzgerald, Ulrich Moebius, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 31, 2019
QuantumATK: an integrated platform of electronic and atomic-scale modelling toolsSøren Smidstrup, Troels Markussen, Pieter Vancraeyveld, et al.
Metabolic Engineering|February 4, 2023
Laboratory evolution reveals general and specific tolerance mechanisms for commodity chemicalsRebecca M Lennen, Hyun Gyu Lim, Kristian Jensen, et al.
Journal of Medicinal Chemistry|April 28, 2022
Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational PlatformHaifeng Tang, Kristian Jensen, Evelyne Houang, et al.
International Journal of Biological Sciences|February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genesLiwen Zhang, Timothy McCabe, Jon H Condra, et al.
Pageof 5